Back to Results
First PageMeta Content
Drug discovery / Phosphoinositide 3-kinase inhibitor / Phosphoinositide 3-kinase / Histone deacetylase / AKT / Multiple myeloma / T cell / CD40 / Hematological malignancy / Medicine / Hematologic neoplasms / Lymphoma


DUAL FUNCTION HDAC AND PI3K INHIBITOR CUDC-907 AFFECTS CANCER CELLS AND THE TUMOR MICROENVIRONMENT IN HEMATOLOGICAL MALIGNANCIES Inc., Lexington, MA; 2Department of Medicine, Memorial Sloan-Kettering Cancer Center, New
Add to Reading List

Document Date: 2014-05-12 19:51:30


Open Document

File Size: 1,49 MB

Share Result on Facebook
UPDATE